This regulation may be cited as the Medicines and Poisons (Medicines) Amendment Regulation 2025.
This regulation commences on 7 April 2025.
This regulation amends the Medicines and Poisons (Medicines) Regulation 2021.
After section 6B—
insert—6CExemption for buying, supplying or possessing stock of immunisation medicines—Act, s 7
(1)For section 7(1) of the Act, the activities prescribed are buying, supplying or possessing stock of an immunisation medicine.(2)However, each activity is prescribed only to the extent—(a)the stock is originally supplied to a registered immunisation service provider by the department; and(b)the activity is for transferring stock from 1 registered immunisation service provider to another registered immunisation service provider; and(c)if the activity is supplying the stock—the registered immunisation service provider supplying the stock notifies the chief executive of the supply as soon as practicable after the supply happens.
5Amendment of sch 1 (Extended practice authorities and departmental standards)
Schedule 1, part 1, table—
omit, insert—
Name
Version
Aboriginal and Torres Strait Islander health practitioners
5
Aboriginal and Torres Strait Islander health workers
3
Indigenous health workers
4
Queensland Ambulance Service
4
Midwives
5
Registered nurses
6
Pharmacists
7
Pharmacists—community pharmacy scope of practice pilot
2
Physiotherapists
2
6Amendment of sch 7, pt 3 (Registered nurses)
(1)Schedule 7, part 3, division 1, section 9, definition prison patient—
omit.(2)Schedule 7, part 3, division 1, section 9—
insert—custodial patient means—(a)a patient in custody at a custodial facility; or(b)a patient being released from a custodial facility into the custody of a court; or(c)a patient being transferred from 1 custodial facility to another custodial facility; or(d)a patient being released from a custodial facility into the community.(3)Schedule 7, part 3, division 5—
omit, insert—A registered nurse who is employed at a custodial facility.
Column 1
DealingColumn 2
MedicineColumn 3
Scope of dealing1
give a treatment dose
(a) an S2, S3 or S4 medicinethe medicine is given for a custodial patient on a prescription
(b) an S8 medicine, other than amfetamine or methylphenidate or an approved opioidthe medicine is given for a custodial patient—
• on a prescription; and• in an amount that is not more than 1 day’s supply (c) amfetamine or methylphenidatethe medicine is given for a patient in custody at, or being released from or transferred to or from, a detention centre or prison—
• on a prescription; and• in an amount that is not more than 7 days’ supply2
repackage
any medicine
the medicine is repackaged—
(a) for giving a treatment dose for a custodial patient on a prescription; and(b) if repackaged in a dose administration aid—under the dose administration aid repackaging guidelines3
possess
an S4 or S8 medicine
the medicine is possessed for a purpose mentioned in this column
7Insertion of new sch 9, pt 1, div 2B
Schedule 9, part 1—
insert—Division 2B Pharmacists employed at public sector health service facilities and private health facilities
In this division—collaborative prescribing protocol, for a public sector health service facility or a private health facility, means a document that—(a)applies to any pharmacist, or a stated class of pharmacist, employed at the facility; and(b)states the circumstances in which any pharmacist or the stated class of pharmacist may prescribe any medicine, or a stated medicine, at the facility; and(c)states the process for any pharmacist or the stated class of pharmacist to prescribe any medicine, or the stated medicine, in collaboration with a medical practitioner or nurse practitioner employed at the facility; and(d)is approved by—(i)if a medicines and therapeutics committee mentioned in section 103(2) is established for the facility—the committee; or(ii)otherwise—the person responsible for the day-to-day management of the facility; and(e)is available for inspection by—(i)a health practitioner employed at the facility; and(ii)the chief executive; and(iii)an inspector; and(iv)a health ombudsman official.public sector health service facility see the Hospital and Health Boards Act 2011, schedule 2.A pharmacist—(a)who is employed at a public sector health service facility or a private health facility; and(b)to whom a collaborative prescribing protocol applies for prescribing at the facility.
Column 1
Dealing
Column 2
Medicine
Column 3
Scope of dealing
1
prescribe
a medicine mentioned in a collaborative prescribing protocol for a public sector health service facility or a private health facility
the medicine is prescribed in the circumstances and in accordance with the process mentioned in the collaborative prescribing protocol for the facility
2
possess
an S4 or S8 medicine
the medicine is possessed for a purpose mentioned in this column
8Amendment of sch 13, pt 7 (Health department employees)
(1)Schedule 13, part 7, section 30—
omit.(2)Schedule 13, part 7, section 31(b), ‘vaccines’—
omit, insert—immunisation medicines
(3)Schedule 13, part 7, section 32, ‘a vaccine’—
omit, insert—an immunisation medicine
(4)Schedule 13, part 7, section 32, ‘registered vaccine service provider’—
omit, insert—registered immunisation service provider
9Amendment of sch 13, pt 8 (Local government environmental health officers)
Schedule 13, part 8, section 34, ‘a vaccine’—
omit, insert—an immunisation medicine
10Amendment of sch 22 (Dictionary)
Schedule 22—
insert—immunisation medicine means a medicine that—(a)is a vaccine; or(b)includes immunoglobulins or monoclonal antibodies for the prevention of an infectious disease.registered immunisation service provider means an entity—(a)approved by the chief executive to carry out activities for an immunisation program managed by an entity of the State or Commonwealth; and(b)listed on a register, maintained by the chief executive, that states the entities approved as mentioned in paragraph (a).